Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Plos One|November 22, 2013
Combination of cytokine responses indicative of latent TB and active TB in Malawian adultsYun-Gyoung Hur, Patricia Gorak-Stolinska, Anne Ben-Smith, et al.
Vaccine|May 21, 2022
Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value conceptsMaarten Postma, Eliana Biundo, Annie Chicoye, et al.
The Journal of Infectious Diseases|November 20, 2004
Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosisT Mark Doherty, Anja W Olsen, Joachim Weischenfeldt, et al.
American Journal of Respiratory and Critical Care Medicine|May 29, 2010
Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humansSammy Place, Virginie Verscheure, Nour de San, et al.
Scientific Reports|December 13, 2016
BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcomeSynne Jenum, Rasmus Bakken, S Dhanasekaran, et al.
Vaccine|March 16, 2010
Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteersJaap T van Dissel, Sandra M Arend, Corine Prins, et al.
Trials|January 12, 2018
A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic areaJemal Hussein, Martha Zewdie, Lawrence Yamuah, et al.
Vaccine|March 23, 2005
Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6Jan A M Langermans, T Mark Doherty, Richard A W Vervenne, et al.
European Geriatric Medicine|June 12, 2018
Vaccination programs for older adults in an era of demographic changeT Mark Doherty, Mark P Connolly, Giuseppe Del Giudice, et al.
BMC Infectious Diseases|January 21, 2012
Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden settingNovel N Chegou, Gillian F Black, Andre G Loxton, et al.
Pageof 10